Elanco Animal Health (ELAN) Other Accumulated Expenses (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly Other Accumulated Expenses came in at $902.0 million in Q2 2026, up 51.34% year-over-year from $596.0 million in Q2 2025, and up 10.4% quarter-over-quarter from $817.0 million in Q1 2026.
Analysis
Elanco Animal Health (ELAN) Other Accumulated Expenses (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Other Accumulated Expenses across 10 years of filings, most recently posting $902.0 million for Q2 2026.
- In Q2 2026, Other Accumulated Expenses rose 51.34% year-over-year to $902.0 million; the TTM figure through Jun 2026 stood at $902.0 million (up 51.34% YoY), while the FY2025 annual figure was $739.0 million, up 58.58% from the prior year.
- Other Accumulated Expenses came in at $902.0 million for Q2 2026 at Elanco Animal Health, up from $817.0 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $902.0 million in Q2 2026 to a low of $377.0 million in Q1 2023.
- Average Other Accumulated Expenses over 5 years is $570.8 million, with a median of $566.5 million recorded in 2023.
- Year-over-year, Other Accumulated Expenses dropped 23.56% in 2022 and jumped 58.58% in 2025.
- Over 5 years, Other Accumulated Expenses stood at $454.0 million in 2022, then slipped by 9.91% to $409.0 million in 2023, then gained by 13.94% to $466.0 million in 2024, then jumped by 58.58% to $739.0 million in 2025, then rose by 22.06% to $902.0 million in 2026.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $902.0 million in Q2 2026, $817.0 million in Q1 2026, and $739.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 902.00 Mn |
| Mar 31, 2026 | 817.00 Mn |
| Dec 31, 2025 | 739.00 Mn |
| Sep 30, 2025 | 665.00 Mn |
| Jun 30, 2025 | 596.00 Mn |
| Mar 31, 2025 | 576.00 Mn |
| Dec 31, 2024 | 466.00 Mn |
| Sep 30, 2024 | 685.00 Mn |
| Jun 30, 2024 | 510.00 Mn |
| Mar 31, 2024 | 574.00 Mn |
| Dec 31, 2023 | 409.00 Mn |
| Sep 30, 2023 | 574.00 Mn |
| Jun 30, 2023 | 559.00 Mn |
| Mar 31, 2023 | 377.00 Mn |
| Dec 31, 2022 | 454.00 Mn |
| Sep 30, 2022 | 435.00 Mn |
| Jun 30, 2022 | 499.00 Mn |
| Mar 31, 2022 | 438.00 Mn |
| Dec 31, 2021 | 433.00 Mn |
| Sep 30, 2021 | 390.00 Mn |